
October 26, 2025
RMi Research Note: Fanning the faith, NVS to acquire RNA
October 24, 2025
RMi Note: Adverum Biotechnologies (ADVM) to be acquired for +$12.47 a share by Eli Lilly (LLY)
October 15, 2025
RMi Research Note: Harvard Apparatus GT (OTCQB): Who is wasting lipstick on this pig?
October 12, 2025
RMi Research Note: Japan’s Takeda (TAK) exits cell and gene therapy (CGT) research with $395 M write-off
September 29, 2025
RMi Research Note: uniQure NV (QURE) Closes 6.736 M share offering priced at $47.50
September 15, 2025
RMi Research note: Sanofi (SAN-PA) has frozen R&D investment decisions in the U.K.
August 28, 2025
RegMed Investors (RMi): New website coming soon! Same insights. Fresh design.
August 13, 2025
RegMed Investors (RMi) Financing note: Compass Therapeutics (CMPX) Launches $129 M offering
August 12, 2025
RegMed Investors (RMi) Financing Note: Adverum Biotechnologies (ADVM) $10 M PIPE priced at $2.24
August 1, 2025
RegMedInvestors (RMi) Finance note: Prime Medicine (PRME) closes 43.7 M share offering at $3.30
July 30, 2025
RegMedInvestors (RMi) Finance note: Prime Medicine (PRME) proposes offering
June 17, 2025
News: RegMedInvestors (RMi) Research Note: Verve Therapeutics (VERV) to be acquired by Eli Lilly (LLY)
May 13, 2025
RegMed Investors (RMi) Financing: Sangamo Therapeutics (SGMO) prices 12,235 M share offering at $0.50 to raise $23 M
March 10, 2025
Beam Therapeutics (BEAM) an offering of 16,151,686 shares priced at $28.48 per share
February 18, 2025
RegMedInvestors (RMi) Financing Note: Solid Biosciences (SLDB) priced 35.739 M share offering with warrants
January 27, 2025
RegMedInvestors (RMi):Sage Therapeutics (SAGE) has unanimously rejected Biogen’s (BIIB) $469 M offer
January 1, 2025
RegMed Investors (RMi): Happy New Year – 2025
December 23, 2024
Merry Christmas and Happy Holiday to All
December 17, 2024
Watching for drones
December 3, 2024
RegMed Investors (RMi) - Q3/24 Cell and Gene Therapy Earnings Scorecard Results
November 27, 2024
Happy Thanksgiving ... giving thanks and be SAFE!
November 7, 2024
RegMed Investors (RMi) Research Note: Q3/24 earnings reporting dates
October 3, 2024
RegMedInvestors (RMi) Research Note: Editas Medicine asset sale raises $57+ M non -dilutive financing
September 10, 2024
RegMed Investors (RMi) Research Note: Ionis Pharmaceuticals (IONS) prices a $500.3 M public offering
August 30, 2024
RegMed Investors (RMi) Research Note: Harvard Apparatus RT (OTCQB: HRGN) raises $5 M without name identification
2 hours 44 min ago
RMi Closing Bell: Fear
11 hours 8 min ago
RMi pre-open: No easing of pain
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors